The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Hormonal Intrauterine Devices (IUDs) Market In 2026, And How Will Its Value Evolve By 2030?
The market size for hormonal intrauterine devices (iuds) has expanded significantly in recent years. It will grow from $2.87 billion in 2025 to $3.18 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. Historically, this expansion has been driven by factors such as enhanced knowledge of family planning choices, broader women’s reproductive health initiatives, a greater inclination towards long-acting birth control, the presence of hormonal device options, and backing from public health campaigns.
The market for Hormonal Intrauterine Devices (IUDs) is poised for substantial expansion over the next few years. It is projected to reach $4.74 billion by 2030, growing at a robust compound annual growth rate (CAGR) of 10.5%. This expected market growth can be attributed to several factors, including the increasing demand for non-surgical contraceptive methods, a greater emphasis on menstrual health management, the broadening of access in developing markets, rising investments in women’s health technologies, and continued innovation in hormone delivery systems. Key trends anticipated during this period involve the increasing uptake of low-dose hormonal IUDs, a surging preference for long-acting reversible contraceptives, a growing demand for frameless device designs, the expansion of therapeutic IUD applications, and an intensified focus on patient comfort and safety.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp
Which Important Drivers Are Guiding The Hormonal Intrauterine Devices (IUDs) Market Growth?
The rising incidence of unplanned pregnancies is projected to drive expansion within the hormonal intrauterine devices market. Unplanned pregnancies are defined as conceptions that were not intended or wished for at the moment they occurred. Multiple factors contribute to these pregnancies, such as the failure of contraception, insufficient availability of birth control, improper application of contraceptive methods, or instances of sexual violence. Restricted availability of reliable contraception escalates the likelihood of unplanned pregnancies, diminishing individuals’ autonomy regarding their reproductive decisions. Hormonal IUDs demonstrate high efficacy in pregnancy prevention, boasting a failure rate of less than 1%. These devices offer extended protection, lasting 3 to 7 years, contingent on the specific type, making them a dependable choice for individuals aiming to prevent unplanned conceptions. As an illustration, in July 2025, data from the Society for Family Planning, a US professional body, indicated that abortions increased to 1.14 million in 2024, up from 1.05 million documented in 2023. Consequently, the surge in unplanned pregnancies is fueling expansion in the hormonal intrauterine devices market.
How Are Different Segments Classified In The Hormonal Intrauterine Devices (IUDs) Market Segment Analysis?
The hormonal intrauterine devices (iuds) market covered in this report is segmented –
1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices
2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices
3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices
4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications
Subsegments:
1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions
2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions
3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis
What Trends Are Influencing The Evolution Of The Hormonal Intrauterine Devices (IUDs) Market?
Leading companies in the hormonal intrauterine devices market are concentrating on developing enhanced solutions, such as levonorgestrel intrauterine devices (IUDs), to mitigate menstrual bleeding and cramps. These levonorgestrel intrauterine devices (IUDs) are long-acting birth control options placed inside the uterus, continuously releasing the hormone levonorgestrel to prevent pregnancy. For instance, in October 2024, Medicines360, a US-based nonprofit organization, launched Avibela, a 52 mg levonorgestrel intrauterine device (IUD) in Zambia. This device serves two primary functions: providing up to eight years of pregnancy prevention and up to five years of relief from heavy menstrual bleeding. Its contraceptive effect is achieved by making cervical mucus denser, which stops sperm from reaching the uterus. For heavy bleeding, it works by thinning the uterine lining, thereby helping to reduce menstrual flow.
Who Are The Companies Driving Activity In The Hormonal Intrauterine Devices (IUDs) Market?
Major companies operating in the hormonal intrauterine devices (iuds) market are Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Teva UK Limited, Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.
Get The Full Hormonal Intrauterine Devices (IUDs) Market Report:
Where Is The Hormonal Intrauterine Devices (IUDs) Market Most Concentrated Geographically?
North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (iuds) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Hormonal Intrauterine Devices (IUDs) Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=19091&type=smp
Browse Through More Reports Similar to the Global Hormonal Intrauterine Devices (IUDs) Market 2026, By The Business Research Company
Contraceptive Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report
Hormonal Contraceptives Market Report 2026
https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report
Gynecological Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/gynecological-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model